| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 5.14M | — |
| Operating expense | — | — |
| Net income | -7.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VVOS returned -93.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -85.8% |
| 1 year | -93.2% |
| 5 years | -99.8% |
| All-time high | $187.75 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VVOS would be worth today ›No. Vivos Therapeutics, Inc. has not paid a dividend in the past 12 months.
Vivos Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol VVOS.
Vivos Therapeutics, Inc. is part of the Healthcare sector.
Vivos Therapeutics, Inc. has a market cap of 5.78M USD, based on the latest quote.
Vivos Therapeutics, Inc. is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
